Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stereotyping | 1 | 2020 | 39 | 0.690 |
Why?
|
| Pre-Exposure Prophylaxis | 2 | 2018 | 179 | 0.650 |
Why?
|
| Aneurysm, False | 2 | 2008 | 45 | 0.610 |
Why?
|
| Prenatal Care | 1 | 2020 | 253 | 0.600 |
Why?
|
| Students, Medical | 2 | 2018 | 262 | 0.580 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 578 | 0.540 |
Why?
|
| Angiography | 2 | 2008 | 174 | 0.370 |
Why?
|
| Hepatic Artery | 1 | 2008 | 49 | 0.310 |
Why?
|
| Scrotum | 1 | 2008 | 23 | 0.310 |
Why?
|
| Jugular Veins | 1 | 2008 | 38 | 0.310 |
Why?
|
| Penis | 1 | 2008 | 37 | 0.310 |
Why?
|
| Umbilical Arteries | 1 | 2008 | 41 | 0.310 |
Why?
|
| Vena Cava Filters | 1 | 2008 | 50 | 0.300 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 239 | 0.290 |
Why?
|
| Biopsy | 2 | 2008 | 1036 | 0.290 |
Why?
|
| Prosthesis Implantation | 1 | 2008 | 138 | 0.280 |
Why?
|
| Embolization, Therapeutic | 1 | 2008 | 178 | 0.270 |
Why?
|
| Graft vs Host Disease | 1 | 2008 | 212 | 0.270 |
Why?
|
| Spinal Cord | 1 | 2008 | 347 | 0.260 |
Why?
|
| Arginine | 2 | 2004 | 238 | 0.240 |
Why?
|
| Argininosuccinate Synthase | 1 | 2004 | 2 | 0.230 |
Why?
|
| Citrullinemia | 1 | 2004 | 2 | 0.230 |
Why?
|
| Arginase | 1 | 2002 | 27 | 0.200 |
Why?
|
| Ultrasonography, Interventional | 3 | 2013 | 123 | 0.200 |
Why?
|
| Hydrolases | 1 | 2002 | 51 | 0.200 |
Why?
|
| Age Determination by Skeleton | 1 | 2021 | 16 | 0.190 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 98 | 0.180 |
Why?
|
| Young Adult | 6 | 2020 | 10455 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 144 | 0.170 |
Why?
|
| Radiography | 1 | 2021 | 812 | 0.160 |
Why?
|
| Racism | 1 | 2020 | 102 | 0.150 |
Why?
|
| Nephrotic Syndrome | 1 | 2018 | 24 | 0.150 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 172 | 0.150 |
Why?
|
| Nitric Oxide | 1 | 2002 | 823 | 0.140 |
Why?
|
| Adolescent | 6 | 2021 | 17831 | 0.130 |
Why?
|
| Macrophages | 1 | 2002 | 1261 | 0.130 |
Why?
|
| Ischemia | 1 | 2018 | 362 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2018 | 335 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 182 | 0.110 |
Why?
|
| Fibrosarcoma | 1 | 2012 | 20 | 0.100 |
Why?
|
| Peripheral Arterial Disease | 1 | 2018 | 380 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 666 | 0.100 |
Why?
|
| Humans | 13 | 2021 | 114623 | 0.100 |
Why?
|
| Sclerosing Solutions | 1 | 2011 | 9 | 0.100 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2012 | 90 | 0.100 |
Why?
|
| Sclerotherapy | 1 | 2011 | 19 | 0.100 |
Why?
|
| Lymphatic Abnormalities | 1 | 2011 | 18 | 0.090 |
Why?
|
| Doxycycline | 1 | 2011 | 55 | 0.090 |
Why?
|
| Hand | 1 | 2012 | 134 | 0.090 |
Why?
|
| Liver Diseases | 1 | 2013 | 255 | 0.090 |
Why?
|
| Carcinoma | 1 | 2012 | 198 | 0.090 |
Why?
|
| Neoplasms | 1 | 2004 | 2097 | 0.090 |
Why?
|
| Male | 8 | 2021 | 55554 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 4620 | 0.080 |
Why?
|
| Punctures | 1 | 2008 | 36 | 0.080 |
Why?
|
| Pregnancy | 1 | 2020 | 5517 | 0.080 |
Why?
|
| Platelet Count | 1 | 2008 | 81 | 0.080 |
Why?
|
| Liver Function Tests | 1 | 2008 | 103 | 0.080 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 64 | 0.070 |
Why?
|
| Abnormalities, Multiple | 1 | 2008 | 178 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 209 | 0.070 |
Why?
|
| Female | 7 | 2021 | 59466 | 0.070 |
Why?
|
| Contrast Media | 1 | 2008 | 345 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 1342 | 0.060 |
Why?
|
| Child | 5 | 2021 | 18404 | 0.060 |
Why?
|
| HIV Infections | 1 | 2018 | 2469 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2018 | 9084 | 0.050 |
Why?
|
| Pharmacogenetics | 1 | 2004 | 149 | 0.050 |
Why?
|
| United States | 1 | 2018 | 12176 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2004 | 849 | 0.050 |
Why?
|
| Nitric Oxide Synthase | 1 | 2002 | 209 | 0.050 |
Why?
|
| Radiologists | 1 | 2021 | 35 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 511 | 0.050 |
Why?
|
| Swine | 1 | 2002 | 700 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1629 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2279 | 0.040 |
Why?
|
| Infant | 3 | 2021 | 7959 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 1230 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 821 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2002 | 719 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2021 | 9108 | 0.040 |
Why?
|
| Fasciotomy | 1 | 2018 | 16 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2018 | 39 | 0.040 |
Why?
|
| Ankle Brachial Index | 1 | 2018 | 30 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2008 | 5043 | 0.040 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 124 | 0.040 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 117 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1691 | 0.040 |
Why?
|
| Heparin | 1 | 2018 | 224 | 0.030 |
Why?
|
| Cell Line | 1 | 2002 | 2635 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 910 | 0.030 |
Why?
|
| Liver | 1 | 2002 | 1634 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2762 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2018 | 550 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 532 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 536 | 0.030 |
Why?
|
| Boston | 1 | 2011 | 75 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2011 | 104 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6217 | 0.020 |
Why?
|
| Mice | 1 | 2002 | 14860 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 30528 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2013 | 12542 | 0.020 |
Why?
|
| Animals | 1 | 2002 | 31694 | 0.010 |
Why?
|